Timosaponin A1
(Synonyms: 知母皂苷A1) 目录号 : GC30611A steroidal saponin with diverse biological activities
Cas No.:68422-00-4
Sample solution is provided at 25 µL, 10mM.
Timosaponin AI is a steroidal saponin that has been found in A. asphodeloides and has diverse biological activities.1,2,3 It is also a metabolite of timosaponin AIII .4 Timosaponin AI inhibits 5-lipoxygenase (5-LO), COX-2, and dipeptidyl peptidase 4 (DPP-4; IC50s = 3.29, 36.43, and 33.25 ?M, respectively).1,2 It reduces total cholesterol and triglyceride levels in 3T3-L1 differentiated adipocytes and increases glucose consumption in insulin-resistant BNL CL.2 mouse embryonic liver cells stimulated with insulin.2 Timosaponin AI is cytotoxic to NRK rat kidney epithelial and MOLM-13 acute myeloid leukemia (AML) cells (EC50s = 0.12 and 0.22 mM, respectively).3
1.Xie, L., Lee, D.Y.-W., Shang, Y., et al.Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MSPhytomedicine77153284(2020) 2.Jiang, S., Wu, X., Wang, Y., et al.The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathwayEur. J. Pharmacol.882173272(2020) 3.Carpinteyro Díaz, A.E., Herfindal, L., Rathe, B.A., et al.Cytotoxic saponins and other natural products from flowering tops of Narthecium ossifragum LPhytochemistry16467-77(2019) 4.Sun, Y., Liu, L., Peng, Y., et al.Metabolites characterization of timosaponin AIII in vivo and in vitro by using liquid chromatography-mass spectrometryJ. Chromatogr. B Analyt. Technol. Biomed. Life Sci.997236-243(2015)
Cas No. | 68422-00-4 | SDF | |
别名 | 知母皂苷A1 | ||
Canonical SMILES | C[C@@]12[C@]3([H])[C@](O[C@]4(CC[C@H](C)CO4)[C@H]3C)([H])C[C@@]1([H])[C@@]5([H])[C@]([C@@]6([C@](C[C@@H](O[C@]7([H])O[C@@H]([C@H](O)[C@H](O)[C@H]7O)CO)CC6)([H])CC5)C)([H])CC2 | ||
分子式 | C33H54O8 | 分子量 | 578.78 |
溶解度 | DMSO : 31.25 mg/mL (53.99 mM; ultrasonic and warming and heat to 60°C) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.7278 mL | 8.6389 mL | 17.2777 mL |
5 mM | 0.3456 mL | 1.7278 mL | 3.4555 mL |
10 mM | 0.1728 mL | 0.8639 mL | 1.7278 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet